🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Virginia Steen

Georgetown University

ORCID: 0000-0002-6333-0133
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.721Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi‐center US‐based longitudinal registry

International Journal of Rheumatic Diseases(2021)10.1111/1756-185x.14253
Top 38%
0.509DataRank
Top 38%11 citations

John M. VanBuren, Emily Startup, Shervin Assassi, Elana J. Bernstein, Leland W.K. Chung +12 more

Papers

Driven by 19 papers — median percentile 49. Top paper: “Predictive Significance of Serum Interferon‐Inducible Protein Score for Response to Treatment in Systemic Sclerosis–Related Interstitial Lung Disease”.

Predictive Significance of Serum Interferon‐Inducible Protein Score for Response to Treatment in Systemic Sclerosis–Related Interstitial Lung Disease

Arthritis & Rheumatology(2020)10.1002/art.41627
N/A
1.2DataRank · unranked
41 citations

Ning Li, Elizabeth R. Volkmann, Maureen D. Mayes, Dennis Rünger, Binwu Ying +18 more

Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial

The Lancet Rheumatology(2020)10.1016/s2665-9913(20)30237-x
N/A
1.1DataRank · unranked
48 citations

Cathie Spino, Richard McLain, Sindhu R. Johnson, Christopher P. Denton, Jerry A. Molitor +27 more

Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi‐center US‐based longitudinal registry

International Journal of Rheumatic Diseases(2021)10.1111/1756-185x.14253
Top 38%
0.509DataRank
Top 38%11 citations

John M. VanBuren, Emily Startup, Shervin Assassi, Elana J. Bernstein, Leland W.K. Chung +12 more

Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study

Lara D. Veeken(2025)10.1093/rheumatology/keaf062
N/A
0.281DataRank · unranked
4 citations

Richard M. Silver, Virginia Steen, Daniel E. Furst, Flavia V. Castelino, Marcin A. Trojanowski +10 more

The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation

Clinical and Experimental Rheumatology(2022)10.55563/clinexprheumatol/04rauu
Top 63%
0.212DataRank
Top 63%2 citations

Tracy Frech, Shervin Assassi, Jessica Gordon, Elana J. Bernstein, Virginia Steen +13 more

Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort

Arthritis Research & Therapy(2021)10.1186/s13075-021-02548-1
N/A
0DataRank · unranked
69 citations

Alain Lescoat, Suiyuan Huang, Jessica Gordon, Monique Hinchcliff, Ami A. Shah +15 more

A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc

Best Practice & Research Clinical Rheumatology(2021)10.1016/j.berh.2021.101707
N/A
0DataRank · unranked
44 citations

Tracy Frech, Cecília Varjú, Robyn T. Domsic, Jessica Farrell, Jessica Gordon +48 more

Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design

Lara D. Veeken(2021)10.1093/rheumatology/keab075
N/A
0DataRank · unranked
20 citations

Shiyao Gao, Maureen Laffoon, Stephen R. Wisniewski, Yuqing Zhang, Virginia Steen +3 more

Racial Disparities in Systemic Sclerosis: Short‐ and Long‐Term Outcomes Among African American Participants of SLS I and II

ACR Open Rheumatology(2020)10.1002/acr2.11206
N/A
0DataRank · unranked
14 citations

Virginia Steen, Ning Li, Michael D. Roth, Philip J. Clements, Daniel E. Furst +7 more

Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry

Lara D. Veeken(2021)10.1093/rheumatology/keab569
N/A
0DataRank · unranked
4 citations

Laura C. Pinheiro, Deanna Jannat‐Khah, Irina Sobol, Jackie Szymonifka, Jackie Finik +3 more

Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease

Lara D. Veeken(2022)10.1093/rheumatology/keac557
N/A
0DataRank · unranked
17 citations

Kevin M. Brown, Ella A. Kazerooni, Donald P Tashkin, Shervin Assassi, Fernando J. Martínez +48 more

A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials

Lara D. Veeken(2022)10.1093/rheumatology/keac501
N/A
0DataRank · unranked
7 citations

Thomas A. Medsger, Shiyao Gao, Maureen Laffoon, Suiyuan Huang, Stephen R. Wisniewski +5 more

Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline

American Journal of Respiratory and Critical Care Medicine(2023)10.1164/rccm.202306-1113st
N/A
0DataRank · unranked
164 citations

Sydney B. Montesi, Richard M. Silver, Tanzib Hossain, Madalina Macrea, Derrick Herman +19 more

Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102104
N/A
0DataRank · unranked
6 citations

Mitchell R. Knisely, Donald E. Bailey, Tamara J. Somers, Linda Kwakkenbos, Marie‐Eve Carrier +95 more

CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization

Lara D. Veeken(2023)10.1093/rheumatology/kead176
N/A
0DataRank · unranked
2 citations

Tracy Frech, Shervin Assassi, Brian Skaug, Jessica Gordon, Kimberly S. Lakin +24 more

Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study

The Lancet Rheumatology(2025)10.1016/s2665-9913(24)00403-x
N/A
0DataRank · unranked
20 citations

Dinesh Khanna, Enrico De Lorenzis, Stefano Di Donato, Antonio Carriero, Rebecca L. Ross +15 more

Hand Swelling and Other Non–Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts

Arthritis & Rheumatology(2025)10.1002/art.43237
N/A
0DataRank · unranked
4 citations

Shervin Assassi, Maureen D. Mayes, Zsuzsanna H. McMahan, Meng Zhang, Julio Charles +28 more

Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?

Clinical Rheumatology(2020)10.1007/s10067-020-05467-9
N/A
0DataRank · unranked
11 citations

John M. VanBuren, Emily Startup, Shervin Assassi, Elana J. Bernstein, Flavia V. Castelino +12 more

A Novel Utility to Correct for Plate/Batch/Lot and Nonspecific Binding Artifacts in Luminex Data

The Journal of Immunology(2020)10.4049/jimmunol.2000017
N/A
0DataRank · unranked
18 citations

Yael Rosenberg‐Hasson, Kathleen D. Kolstad, Virginia Steen, Leland W.K. Chung, Holden T. Maecker